Publication | Closed Access

Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid – A prospective study over 6 years

Bone DiseaseZoledronic AcidUrologyBone HealthProstatic DiseaseMedicineOsteoporosisOrthopaedic SurgeryBisphosphonate-related Osteonecrosis